Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Sosei Group Corporation
Sosei Group Corporation
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Metrion and Sosei Heptares to explore structure-based drug design
Sosei Heptares will have exclusive global rights to all molecules identified
Research & Development
Sosei Heptares and PharmEnable enter drug discovery collaboration
The companies will jointly conduct and share the costs of the discovery and development program and will co-own any resulting products
Research & Development
Sosei Heptares announces €40 million Medicxi investment
Two asset-centric companies have been formed to develop Sosei’s novel therapies for neurological diseases funded by Medicxi
Recruitment
Sosei appoints Interim CFO
Media
Changes in executive management at Sosei
Manufacturing
Heptares founder Richard Henderson receives Nobel Prize in Chemistry 2017
Finance
Heptares Therapeutics enters agreement with Daichi Sankyo
The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Subscribe now